 |
|
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
Clin Mol Hepatol. 2024;30(4):585-619. Published online 2024 Jul 1 DOI: https://doi.org/10.3350/cmh.2024.0222
|
|
Citations to this article as recorded by
 Crosstalk-free two-channel visualization and precise assessment of autophagy-regulated hepatic ischemia-reperfusion injury by a two-photon fluorescent probe
Qing Chang, Qi Wang, Jingyu Zhang, Yan Fang, Jiale Ou, Huimin Zhou, Xianyun Xu, Qi Chen, Yan Feng, Xiangming Meng
Sensors and Actuators B: Chemical.2025; 431: 137402. CrossRef Sinensetin attenuates hepatic ischemia-reperfusion injury through suppressing GRP78/CHOP-mediated endoplasmic reticulum (ER) stress in mice
Yihong Yang, Guanghua Xiong, Huangqi Shi, Yulin Peng, Jinghong Liu, Yaxuan Jiang, Min Lu, Hongbo Liu, Yong Liu
Frontiers in Pharmacology.2025;[Epub] CrossRef Biomedical applications of fluorescent probes for detecting ischemia-reperfusion injury in different organs
Xinying Jing, Song Han, Yi Yang, Youbo Lai, Weiying Lin
Coordination Chemistry Reviews.2025; 534: 216607. CrossRef Study on the Role of Schisandrin B in Ameliorating Hepatic Ischemia-Reperfusion Injury by Modulating Hepatocyte Autophagy
Zhao Fei, Pan Haihang, Chen Xueyang, Shen Miao
Iranian Journal of Pharmaceutical Research.2025;[Epub] CrossRef Mesenchymal stem cell-derived exosomes: an emerging therapeutic strategy for hepatic ischemia-reperfusion injury
Bo Zhao, Jiping Wei, Zijian Jiang, Yiming Long, Yan Xu, Botao Jiang
Stem Cell Research & Therapy.2025;[Epub] CrossRef Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma
Xinyue Liu, Yilin Cai, Yuanhao Zhang, Hetian Zhang, Sisi Tian, Yuxia Gong, Qinmei Song, Xiaotong Chen, Xiao Ma, Yueqiang Wen, Yu Chen, Jinhao Zeng
Pharmacological Research.2024; 210: 107526. CrossRef
|